+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Unveiling Clinical Pharmacogenomics - Drug Discovery TOE

  • ID: 4012934
  • Report
  • 15 pages
  • Frost & Sullivan
1 of 2
This edition of the Drug Discovery TOE depicts trends across clinical pharmacogenomics exemplified with prospective innovations worldwide. Although still much research needs to be carried out to leverage genomic information in the development of more personalized and cost-effective strategies in drug discovery and development, the impact of clinical pharmacogenomics in precision medicine is decisive.
The corresponding patent scenario is depicted, along with the industry interactions.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 2
Trend Overview
  • Key Facts and Findings: Patents as the Vital Component
Technology Profiles
  • Software Analytics Supporting Clinical Pharmacogenomics
  • Increased Treatment Efficacy through Pharmacogenomics Testing
  • Clinical Best Practices Based on Pharmacogenomics Tests
  • Screening 50 Pharmacogenomic Genes using a Single Test
  • Addressing Potentially Adverse Drug Interactions
  • Pharmacogenomics Test for Eliminating Drug-related Side Effects
  • Sample Library to Enhance Pharmacogenomics Research
Appendix
  • Patent Analysis
  • Industry Interactions
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Order Online - visit: https://www.researchandmarkets.com/reports/4012934
Adroll
adroll